FDA Studies Criticized by Editors of Leading Medical Journals (written by Lauren Uzdienski @ HealthPointCapital)
Ahead of yesterday's House hearing, entitled Regulatory Reform Series #5 - FDA Medical Device Regulation: Impact on American Patients, Innovation and Jobs, Democrats asked the editors of leading medical journals to review two studies suggesting that the FDA is impeding U.S. device innovation. Their responses were scathing.
Last November, Josh Makower published the results of a survey suggesting that the U.S. regulatory system was "unpredictable and characterized by disruptions and d...
